Cardiovascular&HematologicalDisorders-Drug Targets

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

"The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."

Garry X. Shen
Univ. of Manitoba, Canada

Related Journals

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Targets is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal Current Radiopharmaceuticals is essential reading for all the researchers involved in this field, and this journal is indexed by all the major indexing agencies

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

Related E-Books

Bentham ebook::Anti-Angiogenesis Drug Discovery and Development

Bentham ebook::Anti-Obesity Drug Discovery and Development

Bentham ebook::Frontiers in Anti-Cancer Drug Discovery

Bentham ebook::Frontiers in Cardiovascular Drug Discovery

Bentham ebook::Frontiers in CNS Drug Discovery

Bentham ebook::Frontiers in Drug Design and Discovery

Bentham ebook::Drug Design and Discovery in Alzheimer’s Disease

Bentham ebook::Erythropoietic Stimulating Agents

Bentham ebook::The 1 International Conference on Drug Design and Discovery February 4 - 7, 2008, Dubai, UAE

Bentham ebook::The Search for Antidepressants - An Integrative View of Drug Discovery

Bentham ebook::Translational Animal Models in Drug Discovery and Development

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More

Welcome To
Cardiovascular & Hematological Disorders-Drug Targets

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Exogenous Factors from Venomous and Hematophagous Animals in Drugs and Diagnostic Developments for Cardiovascular and Neurovascular Diseases

Cardiovascular Effects Mediated by Imidazoline Drugs: An Update

Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective

Diagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy

Comprehensive Review on Diabetes Associated Cardiovascular Complications - The Vitamin D Perspective

The Effect of Borage (Echium amoenum) on the Mouse Heart and Hematology Parameters

Pentraxin Level is the Key to Determine Primary Percutaneous Coronary Intervention (PCI) or Fibrinolysis

Factor X Deficiency Due to a Compound Heterozygosis Between a New Mutation (Gla72Asp) in Exon 2 and an Already Known one (Gly154Arg) in Exon 5: Factor X Mar Del Plata1)

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To Cardiovascular & Hematological Disorders-Drug Targets

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Exogenous Factors from Venomous and Hematophagous Animals in Drugs and Diagnostic Developments for Cardiovascular and Neurovascular Diseases

Cardiovascular Effects Mediated by Imidazoline Drugs: An Update

Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective

Diagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy

Comprehensive Review on Diabetes Associated Cardiovascular Complications - The Vitamin D Perspective

The Effect of Borage (Echium amoenum) on the Mouse Heart and Hematology Parameters

Pentraxin Level is the Key to Determine Primary Percutaneous Coronary Intervention (PCI) or Fibrinolysis

Factor X Deficiency Due to a Compound Heterozygosis Between a New Mutation (Gla72Asp) in Exon 2 and an Already Known one (Gly154Arg) in Exon 5: Factor X Mar Del Plata1)

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To
Cardiovascular & Hematological Disorders-Drug Targets